PTX
Click for more information
4.88% 4.3¢ prescient therapeutics limited

Ann: PTX-200 High Overall Response in Ph2a Breast Cancer trial, page-27

  1. Batcher1
    9,159 Posts.
    lightbulb Created with Sketch. 513
    clock Created with Sketch.
    23/12/19
    09:35
    Post #: 42097618
    All ten evaluable patients responded to therapy. The ORR across all patients was 91%. Two patients had pathological complete responses, meaning complete eradication of disease, and all eight remaining patients experienced pathological partial responses.
    PTX Price at posting: 7.9¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 8  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

HIQ HITIQ's sensor-containing mouthguard OK'd by World Rugby specifications board
right-arrow Created with Sketch.
ENR Encounter sniffs 4% niobium across 1.6km of strike in WA
right-arrow Created with Sketch.
EVN Evolution shares up 3% on quarterly results for June showing rise in gold production
right-arrow Created with Sketch.
NEWS AI stocks: What to expect in 2024-25
right-arrow Created with Sketch.
WGX Australian foreign investment regulators greenlight Westgold's buyout of Karora
right-arrow Created with Sketch.
IVR Investigator Resources hits 8m @ 1.06% copper on-site Stuart Shelf JV project acreage
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.3¢ 		Change
0.002(4.88%) 		Mkt cap ! $33.01M
Open High Low Value Volume
4.2¢ 4.3¢ 4.1¢ $12.07K 281.5K

Buyers (Bids)

No. Vol. Price($)
1 100000 4.2¢
 

Sellers (Offers)

Price($) Vol. No.
4.3¢ 15822 1
View Market Depth
Last trade - 12.44pm 19/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.